(Q44431610)

2 December 2017

title

Bezafibrate improves hypertension and insulin sensitivity in humans (English)

1 reference

2 December 2017

Bezafibrate Improves Hypertension and Insulin Sensitivity in Humans (English)

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Cardiology and cardiovascular medicine

30 December 2023

main subject

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

30 December 2023

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

30 December 2023

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

30 December 2023

author name string

Jong Il Kim

1

1 reference

2 December 2017

Takeshi Tsujino

2

1 reference

2 December 2017

Yoshio Fujioka

3

1 reference

2 December 2017

Komei Saito

4

1 reference

2 December 2017

Mitsuhiro Yokoyama

5

1 reference

2 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12733699

30 December 2023

publication date

1 April 2003

1 reference

full work available at URL

2 December 2017

https://www.jstage.jst.go.jp/article/hypres/26/4/26_4_307/_pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12733699

30 December 2023

published in

Hypertension Research

1 reference

2 December 2017

volume

26

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

307-313

1 reference

Insulin resistance seen in non-insulin dependent diabetes mellitus and hypertension

2 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

30 December 2023

3

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity.

30 December 2023

4

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes.

30 December 2023

5

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances

30 December 2023

6

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis

30 December 2023

7

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Pathophysiology and pathogenesis of visceral fat obesity

30 December 2023

8

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids.

30 December 2023

9

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Mechanism of free fatty acid-induced insulin resistance in humans

30 December 2023

10

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Effect of clofibrate on glucose tolerance in maturity onset diabetes

30 December 2023

11

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM

30 December 2023

13

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Improvement of glucose tolerance by bezafibrate in non-obese patients with hyperlipidemia and impaired glucose tolerance.

30 December 2023

15

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Bezafibrate reduces blood glucose in type 2 diabetes mellitus

30 December 2023

16

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Fenofibrate improves insulin sensitivity in connection with intramuscular lipid content, muscle fatty acid-binding protein, and beta-oxidation in skeletal muscle

30 December 2023

17

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

30 December 2023

19

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

30 December 2023

20

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Central obesity, glucose intolerance and other cardiovascular disease risk factors: an old syndrome rediscovered

30 December 2023

21

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

30 December 2023

23

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Hemolysis and Changes in Erythrocyte Membrane Lipids

30 December 2023

24

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

The exchange of phospholipids between rat erythrocytes and plasma, and the translocation of phosphatidylcholine across the red cell membrane, are temperature dependent processes

30 December 2023

25

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Dietary sardine oil increases erythrocyte membrane fluidity in diabetic patients

30 December 2023

26

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function

30 December 2023

27

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Improved insulin sensitivity by bezafibrate in rats: relationship to fatty acid composition of skeletal-muscle triglycerides

30 December 2023

28

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Hyperinsulinemia is a determinant of membrane fluidity of erythrocytes in essential hypertension.

30 December 2023

29

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Gamma linolenic acid attenuates cardiovascular responses to stress in borderline hypertensive rats

30 December 2023

30

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Troglitazone reduces activity of the Na+/H+ exchanger in fructose-fed borderline hypertensive rats

30 December 2023

31

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Restoring trust between patient and doctor

30 December 2023

32

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension

30 December 2023

33

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Effects of eicosapentaenoic acid on blood pressure, cell membrane fatty acids, and intracellular sodium concentration in essential hypertension

30 December 2023

34

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Calcium-mediated mechanisms of eicosapentaenoic acid-induced relaxation in hypertensive rat aorta

30 December 2023

35

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus

30 December 2023

36

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population.

30 December 2023

37

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Effects induced by olive oil-rich diet on erythrocytes membrane lipids and sodium-potassium transports in postmenopausal hypertensive women

30 December 2023

39

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

30 December 2023

42

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.307

30 December 2023

Identifiers

1 reference

Dimensions Publication ID

2 December 2017

1045644032

0 references

1 reference